However, the in vitro effect of exposure to imatinib on the proliferation or apoptosis of CD34+ cells from patients with CML in the megakaryocytic crisis phase has not been described. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.